SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Bill Wexler who wrote (6609)5/10/1999 6:06:00 PM
From: Mkilloran  Respond to of 7041
 
Bill...nothing wrong in cashing in for some profits...

And there may be more short term bounce up in price.

But Zona lost a lot of credit on Wall Street today and will trade lower over the next few weeks, months. Going to be hard to convince new investors to sink money in Zona at this time.

No FDA approval, no Product, no earnings......no pipeline.

Maybe they should take some of their cash and start searching for a takeover target to stay in the bio tech business.




To: Bill Wexler who wrote (6609)5/10/1999 6:23:00 PM
From: clochard  Read Replies (1) | Respond to of 7041
 
Bill, what do you think of the possiblity of hedgers (and maybe even a few funds) seeing the massive (and possibly growing) short positions, and buying stock like crazy, driving the shorts to cover and the stock price back to $30, creaming everybody in the process? This is what has happened in the past - I doubt there ever was a "normal" investor following for this stock.

Remember, there are a lot of hedgers who can allocate millions of dollar for a squeeze like this....be careful!!!!! They can also pull some more monkeys out of their asses by announcing another product!